TB/Non-TB Mycobacterial Infections
WHO Report: Tuberculosis deaths rise for the first time in more than a decade due to the COVID-19 pandemic.
15 Oct, 2021 | 02:30h | UTCReport: Global tuberculosis report 2021
Commentary: Tuberculosis deaths rise for 1st time in years, due to COVID – Associated Press
Commentary on Twitter (thread – click for more)
🆕 WHO's Global TB Report reveals deaths from #tuberculosis rise for the first time in more than a decade due to the #COVID19 pandemic.
1.5 million people died in 2020 & the number will continue to rise unless urgent action is taken 👉https://t.co/RFmWYIelhq #EndTB pic.twitter.com/33G7sI8K2J
— World Health Organization (WHO) (@WHO) October 14, 2021
Systematic review: Pretomanid for tuberculosis.
6 Oct, 2021 | 08:51h | UTCPretomanid for tuberculosis: a systematic review – Clinical Microbiology and Infection
Related:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO announces updated definitions of extensively drug-resistant tuberculosis
How COVID is derailing the fight against HIV, TB and malaria.
15 Sep, 2021 | 09:01h | UTCHow COVID is derailing the fight against HIV, TB and malaria – Nature
Related:
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Economic impact of tuberculosis mortality in 120 countries and the cost of not achieving the Sustainable Development Goals tuberculosis targets: a full-income analysis.
10 Sep, 2021 | 05:18h | UTCInvited Commentary: The incalculable costs of tuberculosis
Commentaries on Twitter
A strong eeconomic case for ending TB – trillions of dollars in savings. Cost of not acting now is going to be too expensive! @StopTB https://t.co/ffLVTeqOkj
— Suvanand Sahu (@SahuSuvanand) September 5, 2021
Failure to achieve the SDG tuberculosis mortality target by 2030 will lead to profound economic and health losses:
$3·0 trillion will be lost if the target is not met until 2045!!
Sachil Silva, Nim Pathy, @mikereidmd @DrEricGoosby @RifatAtun https://t.co/ipm5vj62IQ @LancetGH pic.twitter.com/fPHDW5eJWE
— Madhu Pai, MD, PhD (@paimadhu) September 3, 2021
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
9 Jun, 2021 | 08:12h | UTCOriginal Guideline: WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment – Drug-Resistant Tuberculosis Treatment
Commentary on Twitter
🆕💥💥@ERSpublications
WHO guidelines on the treatment of drug-resistant TB contain the latest recommendations on shorter or longer all oral treatment regimens for patients with drug-resistant TB, including the medicines to be used& supportive measures https://t.co/qeeftVYdYN pic.twitter.com/4NKNNjz3Gh— Antibiotic Steward 🇵🇸💔Bassam Ghanem (@ABsteward) June 8, 2021
Practice changing | A four-month rifapentine regiment with moxifloxacin is noninferior to the standard 6-month regimen in the treatment of tuberculosis.
6 May, 2021 | 08:56h | UTCCommentary: Four-month TB treatment matches six-month standard of care – Aidsmap
Review and Algorithm: Tuberculosis and the Heart
31 Mar, 2021 | 03:07h | UTCTuberculosis and the Heart – Journal of the American Heart Association
Commentary on Twitter
Tuberculosis cardiac involvement is frequent. A systematic review and a new algorithm for CV TB is now available! https://t.co/QhzUCVWIxA @adribaran @JosePatricioLop @SIAC_cardio pic.twitter.com/AuotMOUjR0
— JAHA (@JAHA_AHA) March 29, 2021
M-A: Incidence and prevalence of tuberculosis in incarcerated populations
25 Mar, 2021 | 08:09h | UTCCommentary: Tuberculosis in prisons: an unintended sentence? – The Lancet Public Health
Commentary on Twitter (thread – click for more)
1/n
Our new study is published for World TB Day in @TheLancetPH investigating the prevalence and incidence of tuberculosis among incarcerated populations! https://t.co/ZXQ2pQk97K pic.twitter.com/ah4ydI3uXr— Leo Martinez (@LeoMarti_EpiTB) March 22, 2021
[Press release – not published yet] Trial of multi drug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
25 Mar, 2021 | 08:10h | UTC
Commentary on Twitter
Promising news improving treatment #MDR #TB https://t.co/Lxjb7LBofy Translating findings to available drugs & diagnostics back it up will be key pic.twitter.com/YGp8d9ixww
— Michael Marks (@dr_michaelmarks) March 24, 2021
WHO Campaign | World Tuberculosis Day 2021: The Clock Is Ticking
24 Mar, 2021 | 08:16h | UTCWorld Tuberculosis Day 2021: The Clock Is Ticking – World Health Organization
WHO Guideline: Screening for Tuberculosis Disease
24 Mar, 2021 | 08:13h | UTCSee also: WHO Operational Handbook on Systematic Screening for Tuberculosis – World Health Organization
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
24 Mar, 2021 | 08:19h | UTCSee also: 1.4 million with tuberculosis, lost out on treatment during first year of COVID-19 – United Nations
Testing strategies for diagnosing tuberculosis in young children
24 Feb, 2021 | 02:05h | UTCSensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young Children – JAMA Pediatrics (free for a limited period)
Editorial: Diagnosing Childhood Tuberculosis: A Small Step Forward (free for a limited period)
Commentary: Diagnosing Pediatric TB in the Resource-Limited Areas – Physician’s Weekly
WHO announces updates on new molecular assays for the diagnosis of tuberculosis (TB) and drug resistance
21 Feb, 2021 | 22:05h | UTC
SR: How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing extrapulmonary tuberculosis and rifampicin resistance?
12 Feb, 2021 | 01:55h | UTC
Commentary on Twitter
How accurate are tests for diagnosing #tuberculosis #TB outside the lungs and rifampicin resistance? This @Cochrane_IDG systematic review found that Xpert Ultra and Xpert MTB/RIF may be helpful in diagnosing extrapulmonary tuberculosis. https://t.co/H79gK5CcR0 pic.twitter.com/bVy88zNpqQ
— The Cochrane Library (@CochraneLibrary) February 5, 2021
WHO announces updated definitions of extensively drug-resistant tuberculosis
29 Jan, 2021 | 01:38h | UTC
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
7 Jul, 2020 | 08:53h | UTC